T. Rowe Price Investment Management, Inc. Cabaletta Bio, Inc. Put Options Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CABA
# of Institutions
146Shares Held
50MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$20.5 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$17.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$11.2 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$9.66 Million0.03% of portfolio
-
Fred Alger Management, LLC New York, NY2.52MShares$9.31 Million0.09% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $107M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...